TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33866933

Group type: COMPARATOR
Intervention: Daily intake of 100 mg oral ferrous fumarate
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Every other day intake of 100 mg oral ferrous fumarate
Number of subjects: 217
Study: 34184596

Group type: EXPERIMENTAL
Intervention: Metacognitive strategy training
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 53
Study: 33006615

Group type: EXPERIMENTAL
Intervention: Cold Atmospheric Plasma Therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Therapy Placebo
Number of subjects: 0
Study: 34260716

Group type: EXPERIMENTAL
Intervention: BNT162b2 vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32052517

Group type: EXPERIMENTAL
Intervention: Ticagrelor plus aspirin
Number of subjects: 675

Group type: COMPARATOR
Intervention: Clopidogrel plus aspirin
Number of subjects: 675
Study: 35258042

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONS) twice per day for 7 days before surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: No ONS
Number of subjects: 120
Study: 33955943

Group type: EXPERIMENTAL
Intervention: Deep sclerectomy with intrascleral collagen implant (DSCI)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Deep sclerectomy with suprachoroidal collagen implant (DSSCI)
Number of subjects: 13
Study: 35028669

Group type: EXPERIMENTAL
Intervention: Surface-treated miniscrews
Number of subjects: 39

Group type: COMPARATOR
Intervention: Non-treated miniscrews
Number of subjects: 39
Study: 34707516

Group type: EXPERIMENTAL
Intervention: Training for Awareness, Resilience and Action (TARA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment (including but not limited to antidepressant medication and/or psychotherapy)
Number of subjects: 0
Study: 32030497

Group type: EXPERIMENTAL
Intervention: PCI with aspiration thrombectomy
Number of subjects: 432

Group type: COMPARATOR
Intervention: Conventional PCI
Number of subjects: 432
Study: 32789453

Group type: EXPERIMENTAL
Intervention: WZB117 with NaF plus EDTA-Na2 (C group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: NaF plus EDTA-Na2 without WZB117 (A group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Citric acid, trisodium citrate, and EDTA-Na2 without WZB117 (B group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: A group (NaF plus EDTA-Na2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: C group (WZB117 with NaF plus EDTA-Na2)
Number of subjects: 80
Study: 33010094

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic remedies
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (no homeopathic treatment)
Number of subjects: 150
Study: 35577034

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (LDX) 10, 20, 30 mg pooled
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (LDX) pooled
Number of subjects: 199
Study: 34085763

Group type: EXPERIMENTAL
Intervention: Motivational interviewing for patients (Arm 1)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Motivational interviewing for patients and caregivers (Arm 2)
Number of subjects: 510

Group type: COMPARATOR
Intervention: Control group (Arm 3)
Number of subjects: 510
Study: 32891803

Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitors
Number of subjects: 783
Study: 35274356

Group type: EXPERIMENTAL
Intervention: Hybrid closed‐loop insulin delivery
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sensor‐augmented pump therapy
Number of subjects: 30
Study: 34193059

Group type: EXPERIMENTAL
Intervention: Discharge 24 hours after cesarean (Group A)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Discharge 48 hours after cesarean (Group B)
Number of subjects: 294
Study: 33846555

Group type: EXPERIMENTAL
Intervention: Colostrum (200 mg/L)
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Transitional milk (171 mg/L)
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Mature milk (126 mg/L)
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Maternal plasma total cholesterol (TC)
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Maternal plasma low-density lipoprotein cholesterol (LDL-C)
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Ethnic comparison (Tibetan vs. Hui)
Number of subjects: 1138
Study: 33507626

Group type: EXPERIMENTAL
Intervention: Integrated nurse-led tele-homecare program
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (standard home care)
Number of subjects: 200
Study: 35780788

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV‐19 (AZD1222) vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32014696

Group type: EXPERIMENTAL
Intervention: Blackbox
Number of subjects: 47

Group type: COMPARATOR
Intervention: LapMentor
Number of subjects: 47
Study: 35710043

Group type: EXPERIMENTAL
Intervention: Low-calorie optimal defaults
Number of subjects: 377

Group type: COMPARATOR
Intervention: Traditional high-calorie default items
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Optimal defaults
Number of subjects: 377

Group type: COMPARATOR
Intervention: Traditional combos
Number of subjects: 377
Study: 33992249

Group type: EXPERIMENTAL
Intervention: Pilates training (2 to 4 weekly sessions for 10 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 35
Study: 32964939

Group type: EXPERIMENTAL
Intervention: Fresh embryo transfer with intensified luteal phase support (1500 IU hCG, oral estradiol 2 mg twice daily, micronized vaginal progesterone 200 mg three times daily)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Freeze-all strategy followed by frozen embryo transfer
Number of subjects: 212
Study: 33894518

Group type: EXPERIMENTAL
Intervention: Blood lead levels (BLLs) of household children (preschool-aged and school-aged)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Blood lead levels (BLLs) of mothers
Number of subjects: 404
Study: 35653590

Group type: EXPERIMENTAL
Intervention: Therapeutic heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prophylactic-dose heparin
Number of subjects: 0
Study: 33268429

Group type: EXPERIMENTAL
Intervention: Use of the study diagnostic aid for hip checks
Number of subjects: 16640

Group type: COMPARATOR
Intervention: Standard care for hip checks
Number of subjects: 16640
Study: 35001815

Group type: EXPERIMENTAL
Intervention: PR + IMT
Number of subjects: 51

Group type: COMPARATOR
Intervention: PR alone
Number of subjects: 51
Study: 32604783

Group type: EXPERIMENTAL
Intervention: Circulating microRNAs in serum of ILA subjects
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (subjects without ILA)
Number of subjects: 81
Study: 33783227

Group type: EXPERIMENTAL
Intervention: BM-MSC (20 × 10^6 cells)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lp-PRP
Number of subjects: 20

Group type: COMPARATOR
Intervention: BM-MSC
Number of subjects: 20
Study: 32416830

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 10 mg Zn/kg feed
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 20 mg Zn/kg feed
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 40 mg Zn/kg feed
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 80 mg Zn/kg feed
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 160 mg Zn/kg feed
Number of subjects: 504

Group type: COMPARATOR
Intervention: Basal diet (27.7 mg/kg Zn)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Dietary Zn supplementation
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Dietary Zn requirements
Number of subjects: 504
Study: 34407032

Group type: EXPERIMENTAL
Intervention: Enhanced mindfulness-based stress reduction (MBSR+)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Stress management for headache (control)
Number of subjects: 98
Study: 35036447

Group type: COMPARATOR
Intervention: Conventional lifestyle intervention plus placebo
Number of subjects: 1945

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention plus placebo
Number of subjects: 1945

Group type: EXPERIMENTAL
Intervention: Conventional lifestyle intervention plus pioglitazone
Number of subjects: 1945

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention plus pioglitazone
Number of subjects: 1945
Study: 33246650

Group type: EXPERIMENTAL
Intervention: internet-based CBT (iCBT)
Number of subjects: 304

Group type: COMPARATOR
Intervention: telephone-delivered CBT (tCBT)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Both interventions (iCBT and tCBT)
Number of subjects: 304
Study: 35848821

Group type: EXPERIMENTAL
Intervention: 5% dextrose prolotherapy (5cc under ultrasound guidance)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Corticosteroid injection (1 ml triamcinolone 40 mg/ml under ultrasound guidance)
Number of subjects: 54
Study: 33783516

Group type: EXPERIMENTAL
Intervention: Shortened duration of adjuvant chemotherapy (3 to 5 months) with CAPOX (capecitabine plus oxaliplatin)
Number of subjects: 485

Group type: COMPARATOR
Intervention: Shortened duration of adjuvant chemotherapy (3 to 5 months) with FOLFOX (5-fluorouracil/leucovorin plus oxaliplatin)
Number of subjects: 485
Study: 32800642

Group type: EXPERIMENTAL
Intervention: Upper-extremity manipulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower-extremity manipulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no manipulation)
Number of subjects: 0
Study: 32208884

Group type: EXPERIMENTAL
Intervention: Methylphenidate plus placebo, Citalopram plus placebo, Citalopram plus Methylphenidate
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Citalopram combined with Tai Chi or health education
Number of subjects: 165
Study: 33210651

Group type: EXPERIMENTAL
Intervention: Essential drugs prescribed
Number of subjects: 2200

Group type: EXPERIMENTAL
Intervention: Antibiotics prescribed
Number of subjects: 2200

Group type: EXPERIMENTAL
Intervention: Medicines prescribed in generic names
Number of subjects: 2200

Group type: EXPERIMENTAL
Intervention: Adequate response on medicine use
Number of subjects: 2200
Study: 37071202

Group type: COMPARATOR
Intervention: Conventional exercise program (Control)
Number of subjects: 36
Study: 32498613

Group type: EXPERIMENTAL
Intervention: Psychological inoculation (PI)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control (education)
Number of subjects: 149
Study: 33137137

Group type: EXPERIMENTAL
Intervention: Low Breastfeeding Performance Index (BPI) scores
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Living alone
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Maternal occupation as merchants
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Attended three antenatal care (ANC) visits
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Attended four antenatal care visits
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Received postnatal care (PNC)
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Poor knowledge on breastfeeding
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Negative attitudes towards breastfeeding
Number of subjects: 605
Study: 36226787

Group type: EXPERIMENTAL
Intervention: Patient-directed arm (0-30 tablets of oxycodone 5 mg)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard arm (30 tablets of oxycodone 5 mg)
Number of subjects: 73
Study: 32167957

Group type: EXPERIMENTAL
Intervention: arm + hand contralaterally controlled functional electrical stimulation
Number of subjects: 67
Study: 35035944

Group type: EXPERIMENTAL
Intervention: SNF472 (7 mg/kg intravenously) three times weekly for 12 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo three times weekly for 12 weeks
Number of subjects: 66
Study: 33336834

Group type: EXPERIMENTAL
Intervention: Extended trading hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control policies
Number of subjects: 0
Study: 33126364

Group type: EXPERIMENTAL
Intervention: Competence training for ASHA workers over 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline competence assessment using a questionnaire and practical evaluation
Number of subjects: 0
Study: 34906376

Group type: EXPERIMENTAL
Intervention: veliparib (throughout)
Number of subjects: 1140

Group type: EXPERIMENTAL
Intervention: veliparib (pooled arms)
Number of subjects: 1140
Study: 33595213

Group type: EXPERIMENTAL
Intervention: Weekly telephone calls by a clinical dietitian for 3 months
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 22
Study: 32910720

Group type: EXPERIMENTAL
Intervention: Morphological vocabulary intervention
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Dynamic assessment of morphological analysis
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Static assessment of morphological analysis
Number of subjects: 111
Study: 33955190

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy plus intensity-modulated radiotherapy (IC+RT)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Concurrent chemotherapy plus IMRT (CCRT)
Number of subjects: 204
Study: 32579549

Group type: EXPERIMENTAL
Intervention: Nutritional supplement containing 2.6g of amino acids and 250 mcg of chromium picolinate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34006256

Group type: EXPERIMENTAL
Intervention: Conventional logistic model with radiologic grouping for predicting RMPP-3
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Conventional logistic model with radiologic grouping plus laboratory values for predicting RMPP-3
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Laboratory values or radiologic grouping for predicting RMPP-5
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Prediction models using predefined fever profiles for predicting RMPP-5
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Neural network models using 12 sequential fever data for predicting RMPP-5
Number of subjects: 716
Study: 32873500

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine–naloxone
Number of subjects: 570

Group type: COMPARATOR
Intervention: Control group (older adults aged ≥26 years)
Number of subjects: 570
Study: 34793521

Group type: EXPERIMENTAL
Intervention: Hybrid training system (HTS) during knee bending exercise
Number of subjects: 10
Study: 33801665

Group type: EXPERIMENTAL
Intervention: Beetroot Juice (BJ) 140 mL (12.8 mmol NO3−)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Beetroot Juice (BJ)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 11
Study: 32405071

Group type: EXPERIMENTAL
Intervention: Continued ACEI/ARB treatment
Number of subjects: 500

Group type: COMPARATOR
Intervention: Temporary discontinuation of ACEI/ARB treatment for 30 days
Number of subjects: 500
Study: 36383269

Group type: EXPERIMENTAL
Intervention: Tandospirone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 0
Study: 33098159

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA) intervention
Number of subjects: 309

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 309
Study: 32955913

Group type: EXPERIMENTAL
Intervention: Triphala (2,000 mg daily for 4 weeks)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Manjistha (2,000 mg daily for 4 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (2,000 mg daily for 4 weeks)
Number of subjects: 31
Study: 36220197

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT) plus weight loss (WL) (hypocaloric diet)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Weight loss (WL) plus sham (stretching)
Number of subjects: 36
Study: 34610941

Group type: EXPERIMENTAL
Intervention: HABIT-ILE therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: High intensity conventional therapy
Number of subjects: 40
Study: 32814489

Group type: EXPERIMENTAL
Intervention: Free-breathing CTPA
Number of subjects: 240

Group type: COMPARATOR
Intervention: Breath-holding CTPA
Number of subjects: 240
Study: 35666875

Group type: EXPERIMENTAL
Intervention: Vaccination of chickens against Newcastle disease
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no vaccination)
Number of subjects: 0
Study: 32459653

Group type: EXPERIMENTAL
Intervention: Daily text message reminders, feedback, and gain-framed nominal financial incentives (Arm 1)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Daily text message reminders and feedback only (Arm 2)
Number of subjects: 125

Group type: COMPARATOR
Intervention: No reminders, feedback, or incentives (Arm 3)
Number of subjects: 125
Study: 35596530

Group type: EXPERIMENTAL
Intervention: ACTT (Asthma Care Transition Team)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ACTT
Number of subjects: 60
Study: 33637110

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 36232176

Group type: EXPERIMENTAL
Intervention: N95-mask
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Surgical mask (SM)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No mask (NM)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: All conditions (N95, SM, NM)
Number of subjects: 19
Study: 32538106

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 58

Group type: COMPARATOR
Intervention: Ultrasound-guided non-flush ligation and stripping of the great saphenous vein
Number of subjects: 58
Study: 35113605

Group type: EXPERIMENTAL
Intervention: Community-based organizations and community clinics screening for mental health symptoms
Number of subjects: 1057

Group type: COMPARATOR
Intervention: Compared to non-Latinx Whites
Number of subjects: 1057
Study: 33319467

Group type: EXPERIMENTAL
Intervention: Cox regression models for predicting ESRD risk
Number of subjects: 141516

Group type: EXPERIMENTAL
Intervention: Nomograms and charts developed from selected variables
Number of subjects: 141516
Study: 35367159

Group type: EXPERIMENTAL
Intervention: Digital guide for IMFS implantation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (IMFS implanted based on clinical experience)
Number of subjects: 40
Study: 33111581

Group type: EXPERIMENTAL
Intervention: Rice bran (30 g/day) plus navy bean (30 g/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fibersol‐2® (10 g/day)
Number of subjects: 20
Study: 35286527

Group type: EXPERIMENTAL
Intervention: Er:YAG laser–activated irrigation with self-etching mode
Number of subjects: 60

Group type: COMPARATOR
Intervention: Passive ultrasonic irrigation (positive control) with self-etching mode
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional syringe irrigation (negative control) with total-etching mode
Number of subjects: 60
Study: 36361500

Group type: EXPERIMENTAL
Intervention: Capacitive‐Resistive Electric Transfer (CRET)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 6
Study: 34370125

Group type: EXPERIMENTAL
Intervention: High Ligation (HL)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Low Ligation (LL)
Number of subjects: 22
Study: 33677037

Group type: EXPERIMENTAL
Intervention: School-level factors
Number of subjects: 26885

Group type: EXPERIMENTAL
Intervention: Positive school climate
Number of subjects: 26885

Group type: EXPERIMENTAL
Intervention: Urban location and higher percentage of free school meals and White British
Number of subjects: 26885
Study: 32219705

Group type: EXPERIMENTAL
Intervention: Feedback about personal QoL results (WHOQOL-BREF and WHOQOL importance measures)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Assessment of QoL without feedback
Number of subjects: 107
Study: 33125288

Group type: EXPERIMENTAL
Intervention: Callous-Unemotional traits
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Conduct Problems
Number of subjects: 289
Study: 33714863

Group type: EXPERIMENTAL
Intervention: Hand massage
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Foot massage
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (standard nursing interventions only)
Number of subjects: 82
Study: 32495698

Group type: EXPERIMENTAL
Intervention: Gardening
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control
Number of subjects: 16
Study: 36365080

Group type: EXPERIMENTAL
Intervention: Ablative fractional laser-assisted delivery of methotrexate (AFL+MTX) therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ablative fractional laser (AFL) therapy
Number of subjects: 22
Study: 33017065

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard of Care (Control)
Number of subjects: 53
Study: 33609344

Group type: EXPERIMENTAL
Intervention: Qigong exercise (QG, n = 20)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (CG, n = 21)
Number of subjects: 41
Study: 33593096

Group type: EXPERIMENTAL
Intervention: ‘Be Sweet to Babies' videos and a tip sheet
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: As per Group 1 plus a motivational interviewing informed Affirmative Statements and Questions (AS&Q)
Number of subjects: 151
Study: 32629392

Group type: EXPERIMENTAL
Intervention: CD133+ bone marrow derived hematopoietic stem cells
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: SH2B3/LNK-silenced hematopoietic stem cell (HSC) clones
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: SH2B3/LNK knockout mice
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Biomarker signature prediction
Number of subjects: 37
Study: 32505710

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention for 6 months
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 78
Study: 33321509

Group type: EXPERIMENTAL
Intervention: Body in Mind Training (BMT)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Quality of Life and Psychoeducation (QoL)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Fluoxetine (FLX)
Number of subjects: 249
Study: 35613766

Group type: EXPERIMENTAL
Intervention: Statins alone or in combination with ezetimibe or proprotein convertase subtilisin/kexin type 9 inhibitors
Number of subjects: 100
Study: 33939245

Group type: EXPERIMENTAL
Intervention: 400 mcg of budesonide daily for 3 months
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo daily for 3 months
Number of subjects: 180